tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kevin Fischbeck, 25 are a SELL (17.61%), 85 are a BUY (59.86%), 32 are a HOLD (22.54%).
Analyst Kevin Fischbeck, currently employed at BAML, carries an average stock price target met ratio of 70.89% that have a potential upside of 21.25% achieved within 226 days.
Kevin Fischbeck’s has documented 297 price targets and ratings displayed on 27 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on OPCH, Option Care Health at 30-Oct-2024.
Analyst best performing recommendations are on CLOV (CLOVER HEALTH INVESTMENTS CORP).
The best stock recommendation documented was for UHS (UNIVERSAL HEALTH SERVICES) at 3/23/2020. The price target of $104 was fulfilled within 16 days with a profit of $33.53 (47.58%) receiving and performance score of 29.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
$4
$1.3 (48.15%)
$7
28 days ago
(08-Oct-2024)
2/6 (33.33%)
$0.85 (26.98%)
7
Buy
$3
$0.3 (11.11%)
$16
1 months 3 days ago
(02-Oct-2024)
2/5 (40%)
$-0.58 (-16.20%)
27
Hold
$4
$1.3 (48.15%)
$12
2 months 27 days ago
(09-Aug-2024)
5/12 (41.67%)
$-1.52 (-27.54%)
33
Buy
$9
$6.3 (233.33%)
$9
2 months 28 days ago
(08-Aug-2024)
0/5 (0%)
$3.4 (60.71%)
Buy
$8
$5.3 (196.30%)
$8
2 months 29 days ago
(07-Aug-2024)
0/6 (0%)
$2.36 (41.84%)
Which stock is Kevin Fischbeck is most bullish on?
Which stock is Kevin Fischbeck is most reserved on?
What Year was the first public recommendation made by Kevin Fischbeck?
